Gut Bacteria Affect Metabolism of Parkinson’s Therapy Levodopa, Study Shows
Levodopa, one of the main medicines used to treat Parkinson’s symptoms, can be converted into dopamine by gut…
Articles by Catarina Silva, MSc
Inexpensive Hand-Tracker Accurately Measures Bradykinesia in Parkinson’s Patients, Small Study Suggests
An inexpensive off-the-shelf hand-tracker can objectively and reliably measure Parkinson’s disease-related slowness of movement (bradykinesia) over time, both…
Subjective Cognitive Decline Could Help Predict Parkinson’s Dementia, Study Contends
Subjective cognitive decline in Parkinson’s disease could predict the development of dementia. As such, a suitable cognitive screening…
Parkinson’s Subtypes May Predict Disease Course and Survival, Study Suggests
Subtyping Parkinson’s disease at diagnosis may predict disease course and survival, providing both doctors and patients with a more…
Cognitive Performance in Parkinson’s Linked to Sleep Efficiency, Study Shows
University of São Paulo researchers have found that Parkinson’s patients with dementia sleep less and less efficiently, which…
Abnormal Brain Cell Type Leads to Parkinson’s-Related Neurodegeneration, Study Contends
Scientists have found that an abnormal version of brain cells called astrocytes contribute to the accumulation of alpha-synuclein protein, the…
Genetic Variant Predetermines Risk of Cognitive Decline in Parkinson’s, Research Suggests
Researchers have found that Parkinson’s patients whose cognitive ability is intact, but who have a specific genetic variant, have significantly less…
Changes in Gait, Cognition May Be Early Signs of Idiopathic Parkinson’s, Research Suggests
Changes in gait and cognition precede a diagnosis of idiopathic (without known cause) Parkinson’s disease, and may occur earlier than typical …
Engineered Stem Cells Could Be Next Parkinson’s Treatment, Researchers Say
Cutting out a portion of or removing a gene linked to Parkinson’s disease protects against the formation of toxic…
PF-360 Provides Some Benefits But Does Not Improve Dopaminergic Function, Mouse Study Shows
Treatment with PF-360, an investigational leucine-rich repeat kinase 2 (LRRK2) inhibitor, can efficiently decrease LRRK2’s phosphorylation levels, known to be…